Stockreport

Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight [Yahoo! Finance]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF launch of emerging therapies such as targeting SIRP-a/ß1/? (ELA026), targeting Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) (Plonmarlimab), IL-18 inhibitor [Read more]